Article

A novel hyperinflammation clinical risk tool, HI5-NEWS2, predicts mortality following early dexamethasone use in an observational cohort of hospitalised COVID-19 patients

2021-06-18

Abstract excerpt

<h4>Background</h4> The success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of Sars-CoV-2 infection may predominantly reflect its anti-inflammatory action against a hyperinflammation (HI) response. It is likely that there is substantial heterogeneity in HI responses in COVID-19. <h4>Methods</h4> Blood CRP, ferritin, neutrophil, lymphocyte and platelet counts were scored to assess HI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 42fef29a-aa02-578e-9536-e2dbd46fe899
DOI: 10.1101/2021.06.16.21259011

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A novel hyperinflammation clinical risk tool, HI5-NEWS2, predicts mortality following early dexamethasone use in an observational cohort of hospitalised COVID-19 patientsDOI 10.1101/2021.06.16.21259011Read

A Novel Hyperinflammation Clinical Risk Tool, HI5-NEWS2, Predicts Mortality Following Early Dexamethasone Use in an Observational Cohort of Hospitalised COVID-19 PatientsSemantic proximity Read

Inflammatory phenotyping predicts clinical outcome in COVID-19.Semantic proximity Read

National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - A prospective cohort studySemantic proximity Read

Immunological and Biochemical Biomarker Alterations Among SARS-COV-2 Patients with Varying Disease Phenotypes in UgandaSemantic proximity Read

Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality.Semantic proximity Read

Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.Semantic proximity Read

A Differential Therapeutic Consideration for use of Corticosteroids According to Established COVID-19 Clinical Phenotypes in Critically Ill PatientsSemantic proximity Read

Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.Semantic proximity Read

<i>IFIH1</i> rs1990760 variants, systemic inflammation and outcome in critically-ill COVID-19 patientsSemantic proximity Read

Cortisol as an Independent Predictor of Unfavorable Outcomes in Hospitalized COVID-19 PatientsSemantic proximity Read

Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trial.Semantic proximity Read

Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study.Semantic proximity Read